Baylis SA - Search Results

1

Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.

Grabarczyk P, Kalińska A, Kara M, Wieczorek R, Ejduk A, Sulkowska E, Gołębiowska-Staroszczyk S, Matysiak M, Baylis SA, Brojer E. Grabarczyk P, et al. Among authors: baylis sa. J Med Virol. 2011 Jan;83(1):142-9. doi: 10.1002/jmv.21947. J Med Virol. 2011. PMID: 21108352

2

Effects of probe binding mutations in an assay designed to detect parvovirus B19: implications for the quantitation of different virus genotypes.

Baylis SA, Fryer JF, Grabarczyk P. Baylis SA, et al. J Virol Methods. 2007 Jan;139(1):97-9. doi: 10.1016/j.jviromet.2006.09.002. Epub 2006 Oct 12. J Virol Methods. 2007. PMID: 17045660

3

Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland.

Grabarczyk P, Sulkowska E, Gdowska J, Kopacz A, Liszewski G, Kubicka-Russel D, Baylis SA, Corman VM, Noceń E, Piotrowski D, Antoniewicz-Papis J, Łętowska M. Grabarczyk P, et al. Among authors: baylis sa. Transfusion. 2018 May;58(5):1245-1253. doi: 10.1111/trf.14531. Epub 2018 Mar 1. Transfusion. 2018. PMID: 29492976

4

Persistence of novel human parvovirus PARV4 in liver tissue of adults.

Schneider B, Fryer JF, Reber U, Fischer HP, Tolba RH, Baylis SA, Eis-Hübinger AM. Schneider B, et al. Among authors: baylis sa. J Med Virol. 2008 Feb;80(2):345-51. doi: 10.1002/jmv.21069. J Med Virol. 2008. PMID: 18098166

5

Inactivation and neutralization of parvovirus B19 Genotype 3.

Blümel J, Rinckel LA, Lee DC, Roth NJ, Baylis SA. Blümel J, et al. Among authors: baylis sa. Transfusion. 2012 Jul;52(7):1490-7. doi: 10.1111/j.1537-2995.2012.03573.x. Epub 2012 Feb 17. Transfusion. 2012. PMID: 22339291

6

A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19.

Baylis SA, Buchheit KH. Baylis SA, et al. Vox Sang. 2009 Jul;97(1):13-20. doi: 10.1111/j.1423-0410.2009.01170.x. Epub 2009 May 5. Vox Sang. 2009. PMID: 19416495

7

Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.

Baylis SA, Ma L, Padley DJ, Heath AB, Yu MW; Collaborative Study Group. Baylis SA, et al. Vox Sang. 2012 Apr;102(3):204-11. doi: 10.1111/j.1423-0410.2011.01541.x. Epub 2011 Oct 12. Vox Sang. 2012. PMID: 21988191

8

Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation.

Fryer JF, Delwart E, Bernardin F, Tuke PW, Lukashov VV, Baylis SA. Fryer JF, et al. Among authors: baylis sa. J Gen Virol. 2007 Aug;88(Pt 8):2162-2167. doi: 10.1099/vir.0.82620-0. J Gen Virol. 2007. PMID: 17622618

9

Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: a meeting summary.

Baylis SA. Baylis SA. Vox Sang. 2008 Jan;94(1):74-80. doi: 10.1111/j.1423-0410.2007.00992.x. Vox Sang. 2008. PMID: 18171331

10

Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.

Sakata H, Matsubayashi K, Ihara H, Sato S, Kato T, Wakisaka A, Tadokoro K, Yu MY, Baylis SA, Ikeda H, Takamoto S. Sakata H, et al. Among authors: baylis sa. Transfusion. 2013 Oct;53(10 Pt 2):2556-66. doi: 10.1111/j.1537-2995.2012.03949.x. Epub 2012 Nov 12. Transfusion. 2013. PMID: 23145866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters